Drug Safety Bills on Slow Track Through Congress
WASHINGTON – Fears of another heparin fiasco and the reality of stolen and counterfeit drugs entering the U.S. supply chain have fueled several new bills in Congress, but the wheels of the legislative process are turning slowly.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter